Member Info for Globetrotter184

HarChris i will appear whenever i feel i have to. Let me turn this round. You appear when the price is appreciating and this puts you in the ramper category. Subject closed have no time for petty people like you. Good luck

Hello HarChris Good morning. I will express MY OPINION whenever i feel the need to. I don't need any permission from the likes of you. Have a good day. stay safe.

Agree with you Kat. Price was certainly over inflated and together with lack of news is undermining the credibility in the company. If tox results are delayed further the SP will suffer. Hopefully this will not happen but no guarantees. I have already previously declared that i am a holder at an old price of 2p.

Fully justified in being disappointed.

MattyBoy, i beg to differ. Pfizer would not be interested at this stage in a company who have yet to produce tox results and who have not even started Phase 1 of the clinical trials. Prospects promising yes but the possibility of further delays following inconclusive results is still a possibility. We all know the risks----Galapagos-Orchard Therapetics-Tiziana Life Sciences just to mention a few examples. I am a holder at an average price of the old 2p. So yes disappointed but holding on and appreciate the risks with eyes wide open.

Good observation Basser

Obviously not. RNS wording does not indicate this at all. Patience is a virtue. let's wait till H2 for progress report.

just bought at 65.4. So really spread is fictitious. Good value.

Agree with your reasoning RBM. Future growth post Covid is the key.

Agree with your reasoning RBM. Future growth post Covid is the key.

i can assure you DRB 83 i am not new to the business and open minded enough to take criticism. I simply state my thought. Hope i do not need permission to do so.

Just thinking aloud-----is there a leak of info regarding toxicity............resulting in further delays?

No source and nothing official just my view and conviction from past experiences. May agree or disagree but the SP is reflecting this state of affairs. A steady non-covid alternative source of revenue is needed.

DHSC will not be resolved anytime soon. And when it is no guarantee it will be favourable. Premature talk of a takeover and basically not in NOVACYT shareholders interest as it will reflect the residual cash after dispute ruling and a very modest premium. This company has lost its shine and in my view performance will be mediocre. A catalyst is needed to revive SP in a tangible way but honestly i cannot see any on the horizon.

SP at 3p very possible in this scenario if no news forthcoming. Market hates a void in news flows. Seen it all before nothing new. I am willing to hold but i am fully aware of risk that tox results will not be as good as expected or further trial delays which would torpedo the price. Obviously a result to the contrary would make me and fellow investors very very happy. Just be aware of the risks.

Much more Pav5.. Trial delays or a hefty rights issue possible two scenarios.

Point taken Working. Yes bought in two batches last year. I believe in the research too and that,s why i am holding but still feet on the ground.

Because of the importance of those results and the expectation that the announcement is expected relatively soon , the outcome would in my view have a bearing on the SP direction. I am a holder at average 2p price .

Apart from annoying , it also shows the uncertainty of the outcome of the toxic results. That's was always the initial risk which is part and parcel of the sector.

Grim Tim, i follow your reasoning. But apart from the mathematics the market is always forward looking and therefore more interested in the company's plans post covid which at the moment are just vague talk.